A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors
Seagen Inc.
Seagen Inc.
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb
Actym Therapeutics, Inc.
BerGenBio ASA
NGM Biopharmaceuticals, Inc
UTC Therapeutics Inc.
Pfizer
Second Affiliated Hospital of Guangzhou Medical University
NGM Biopharmaceuticals, Inc
Quadriga Biosciences, Inc.
MacroGenics
Abramson Cancer Center at Penn Medicine
Masonic Cancer Center, University of Minnesota
Chinese PLA General Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Morphotek
University of Chicago
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Anza Therapeutics, Inc.